wydrukuj poleć znajomym zamów materiały
Od ilu lat pracuje Pani/Pan na różnych stanowiskach menedżerskich:

powyżej 20 lat
powyżej 15 lat
powyżej 10 lat
powyżej 5 lat
poniżej 5 lat
jeszcze nie byłam/-em menedżerem
nie chcę być menedżerem


Subskrypcja najnowszych ofert pracy





Nasi partnerzy:

rp.pl
gazeta.pl
onet.pl
interia.pl
wp.pl

Sanofi-aventis appoints New Senior Managers in Emerging Markets 2011.01.08

Paris, France - January 7, 2011 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the appointment of new Senior Managers in Emerging Markets, effective February 1, 2011.

Pharmaceuticals manufacturing site in Beijing, China.
Photo: sanofi-aventis
 

Paris, France - January 7, 2011

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the appointment of new Senior Managers in Emerging Markets, effective February 1, 2011.

Hanspeter Spek - Member of the Executive Committee and the Management Committee - President, Global Operations, sanofi-aventis.
Photo: sanofi-aventis
 
“These appointments reflect the dynamics of our businesses and the opportunities we will continue to seize in those regions in order to reinforce sanofi-aventis’ leadership position in the emerging markets”, declared Hanspeter Spek, President, Global Operations, sanofi-aventis.
“The depth of talent, knowledge and experience of the managers we appointed today make them ideally suited to achieve our ambition”.

Pharmaceuticals manufacturing site in Fawdon, Great Britain.
Photo: sanofi-aventis
 

Patrick Aghanian is appointed Head of the Eurasia Region.

He is currently Head of Russia, and will also take responsibility for Ukraine, Belarus and the Central Asia platform based in Kazakhstan.
He worked in various positions at SC Johnson and Son in purchasing, sales and marketing before joining GlaxoSmithKline in 1995 as General Manager Ukraine, then Russia and CIS.
He then joined Novartis as General Manager Russia, in 2003 and Sandoz Russia in 2007, prior to joining sanofi-aventis as General Manager Russia in 2008.


Thomas Kelly is appointed Head of the Asia Region.

He is currently Head of Greater China and will also take responsibility for the South East Asian region including Thailand, Singapore, Malaysia, Indonesia, Vietnam and the Philippines.
He began his career in marketing at Johnson & Johnson in China and joined Novo Nordisk Biotechnology Co, Ltd as Sales and Marketing Director in 1995 and was appointed General Manager in 1998.
In 1999, he joined Shanghai Schering-Plough in China as General Manager, and sanofi-aventis as General Manager China in 2006.

Pharmaceuticals manufacturing site in Thu Duc, Vietnam.
Photo: sanofi-aventis
 

Heraldo Marchezini is appointed Head of the Latin America Region.

He is currently Head of Brazil.
He began his career with Rhodia and Aventis in Brazil working in various positions in sales and marketing, including Product Manager in consumer healthcare and Hospital and Oncology Director.
He then served as Poland, Baltic Region General Manager for Aventis and was appointed General Manager for Brazil in 2004.

Pharmaceuticals manufacturing site in Sao-Paulo, Brazil.
Photo: sanofi-aventis
 

Jeremy Moulding is appointed Head of the Japan & Pacific Region.

He is currently Head of Japan, Australia and New Zealand and will also take responsibility for Korea.
After having served in Astra-Zeneca for 5 years, Jeremy began his career within the Group in 1998 and has been in marketing and commercial roles in the United Kingdom, and later in general management roles in South Africa, Korea and Australia.


About sanofi-aventis


Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.

 
 
Sanofi-aventis
is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi-aventis Group head office.
Photo: sanofi-aventis
 
Focused on patients’ needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide.

At a glance:

• 2009 sales: €29.3 billion growth of 6.3%

• A broad portfolio of pharmaceutical products: prescription medicines, generics, consumer health care and animal health

• World leader in human vaccines

• A broad and balanced presence on both traditional and emerging markets

• More than 105,000 employees in over 110 countries

Group strategy

Our ambition is to become a diversified global healthcare leader.
Our strategy is built around three priorities to reach its goals and ensure sustainable growth:

• Innovation in Research and Development

• Adaptation of Group structures

• External growth opportunities

For more information, visit Sanofi-aventis on the Internet:

www.sanofi-aventis.com  


Media Relations:

Tel. : (+) 33 1 53 77 44 50
E-mail : MR@sanofi-aventis.com


Investor Relations:

Tel. : (+) 33 1 53 77 45 45
E-mail : IR@sanofi-aventis.com


SOURCE: Sanofi-aventis

http://en.sanofi-aventis.com/press/press.asp  



ASTROMAN magazine


wydrukuj ten artykuł
  strona: 1 z 1
polecamy artykuły
SAMSUNG. The Galaxy Note9 Unpacked 2018 Takes a Leap Toward a More Connected World
SAMSUNG. Nowy Galaxy Note9 - dla tych, którzy pragną mieć wszystko
LANXESS plans to sell remaining 50 percent stake in joint venture ARLANXEO to Saudi Aramco
"Pępowina" zaprojektowana w Warszawie poleci na Marsa. Mechanizm zaprojektowali i wykonali inżynierowie z SENER Polska
Cisco Announces Intent to Acquire Duo Security for USD2.35 billion
NVIDIA. Why GeForce Is the Graphics Platform of The International 2018
Pipistrel Alpha Electro aircraft. First flight of an electric aircraft in Finland
Bridgestone premieres leading-edge products and solutions offering ultimate efficiency, convenience and sustainability at IAA 2018
Harley-Davidson Accelerates Strategy to Build Next Generation of Riders Globally
China-Europe Railway Express (Zhengzhou): The Silk Rail Road Gets on Track
Volkswagen's all-electric I.D. R race car sets a new standard at the world's highest road race at the 2018 Pikes Peak International Hill Climb
The Microsoft Inspire 2018: Opening doors for partner innovation, growth and differentiation
Intercept Sets Distance Record for Lockheed Martin's Hit-to-Kill Patriot Advanced Capability PAC-3 MSE
ESA: New satellite launch extends Galileo's global reach
Atos to acquire American company Syntel to create global digital transformation leader for USD3.4 billion
strona główna  |  oferty pracy  |  executive search  |  ochrona prywatności  |  warunki używania  |  kontakt     RSS feed subskrypcja RSS
Copyright ASTROMAN © 1995-2018. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: TAU CETI.